Literature DB >> 7278081

Disposition of oxazepam in relation to age, sex, and cigarette smoking.

H R Ochs, D J Greenblatt, H Otten.   

Abstract

The kinetics of single 30-mg oral doses of oxazepam were determined in 22 male and nine female volunteers aged 20-86 years. Oxazepam plasma concentrations were measured in multiple plasma samples drawn during 36 h after each dose. Mean kinetic variables in males and females, respectively, were: elimination half-life, 7.5 and 8.5 h; volume of distribution, 0.96 and 1.17 l/kg; clearance, 1.48 and 1.70 ml/min/kg. Sex differences were not significant, nor were any of the kinetic variables significantly related to age. However, oxazepam clearance increased significantly with heavier cigarette smoking (r = 0.48, p less than 0.01). Mean clearance in smokers (1.98 ml/min/kg) was significantly higher than in nonsmokers (1.23 ml/min/kg, p less than 0.01). Thus, smoking is a more important determinant of oxazepam clearance than age or sex.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7278081     DOI: 10.1007/BF01721923

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  21 in total

1.  Effects of aging and liver disease on disposition of lorazepam.

Authors:  J W Kraus; P V Desmond; J P Marshall; R F Johnson; S Schenker; G R Wilkinson
Journal:  Clin Pharmacol Ther       Date:  1978-10       Impact factor: 6.875

2.  Increased sensitivity to nitrazepam in old age.

Authors:  C M Castleden; C F George; D Marcer; C Hallett
Journal:  Br Med J       Date:  1977-01-01

Review 3.  Drug use in the elderly: a review of problems and special considerations.

Authors:  R E Vestal
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546

4.  Effect of age on the pharmacokinetics of diazepam given in conjunction with spinal anesthesia.

Authors:  J Kanto; M Mäenpää; R Mäntylä; R Sellman; E Valovirta
Journal:  Anesthesiology       Date:  1979-08       Impact factor: 7.892

5.  Clinical depression of the central nervous system due to diazepam and chlordiazepoxide in relation to cigarette smoking and age.

Authors: 
Journal:  N Engl J Med       Date:  1973-02-08       Impact factor: 91.245

6.  Oxazepam kinetics: effects of age and sex.

Authors:  D J Greenblatt; M Divoll; J S Harmatz; R I Shader
Journal:  J Pharmacol Exp Ther       Date:  1980-10       Impact factor: 4.030

7.  Toxicity of nitrazepam in the elderly: a report from the Boston Collaborative Drug Surveillance Program.

Authors:  D J Greenblatt; M D Allen
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

Review 8.  Influence of cigarette smoking on drug metabolism in man.

Authors:  W J Jusko
Journal:  Drug Metab Rev       Date:  1979       Impact factor: 4.518

9.  Plasma binding of benzodiazepines in humans.

Authors:  R F Johnson; S Schenker; R K Roberts; P V Desmond; G R Wilkinson
Journal:  J Pharm Sci       Date:  1979-10       Impact factor: 3.534

10.  Relationship between diazepam dose, plasma level, age, and central nervous system depression.

Authors:  M M Reidenberg; M Levy; H Warner; C B Coutinho; M A Schwartz; G Yu; J Cheripko
Journal:  Clin Pharmacol Ther       Date:  1978-04       Impact factor: 6.875

View more
  18 in total

Review 1.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part II).

Authors:  D J Greenblatt; J S Harmatz; R I Shader
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

3.  The concentration of oxazepam and oxazepam glucuronide in oral fluid, blood and serum after controlled administration of 15 and 30 mg oxazepam.

Authors:  Beitske E Smink; Berendina J A Hofman; Albert Dijkhuizen; Klaas J Lusthof; Johan J de Gier; Antoine C G Egberts; Donald R A Uges
Journal:  Br J Clin Pharmacol       Date:  2008-06-28       Impact factor: 4.335

4.  Single dose pharmacokinetics and pharmacodynamics of oral oxazepam in very elderly institutionalised subjects.

Authors:  J Sonne; S Loft; M Døssing; S Boesgaard; F Andreasen
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335

5.  Influence of propranolol coadministration or cigarette smoking on the kinetics of desmethyldiazepam following intravenous clorazepate.

Authors:  H R Ochs; D J Greenblatt; A Locniskar; J Weinbrenner
Journal:  Klin Wochenschr       Date:  1986-12-01

6.  Bioavailability and pharmacokinetics of oxazepam.

Authors:  J Sonne; S Loft; M Døssing; A Vollmer-Larsen; K L Olesen; M Victor; F Andreasen; P B Andreasen
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

7.  The influence of diflunisal on the pharmacokinetics of oxazepam.

Authors:  A M van Hecken; T B Tjandramaga; R Verbesselt; P J de Schepper
Journal:  Br J Clin Pharmacol       Date:  1985-09       Impact factor: 4.335

8.  Pharmacodynamics of the anticonvulsant effect of oxazepam in aging BN/BiRij rats.

Authors:  A M Stijnen; I Postel-Westra; M W Langemeijer; A Hoogerkamp; R A Voskuyl; C F van Bezooijen; M Danhof
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

9.  Sex-difference and the effects of smoking and oral contraceptive steroids on the kinetics of diflunisal.

Authors:  J I Macdonald; R J Herman; R K Verbeeck
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

10.  Disposition of oxazepam in patients on maintenance hemodialysis.

Authors:  H R Ochs; D J Greenblatt; U Klehr
Journal:  Klin Wochenschr       Date:  1984-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.